"Dimethyl Fumarate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A fumarate derivative that is used as a DERMATOLOGIC AGENT in the treatment of PSORIASIS and SKIN DISEASES. It also may be used as an IMMUNOSUPPRESSIVE AGENT in the treatment of MULTIPLE SCLEROSIS.
| Descriptor ID |
D000069462
|
| MeSH Number(s) |
D02.241.081.337.302.500
|
| Concept/Terms |
Dimethyl Fumarate- Dimethyl Fumarate
- Fumarate, Dimethyl
- 2-butenedioic acid, (2E)-, dimethyl ester
- Dimethylfumarate
BG 00012- BG 00012
- 00012, BG
- BG00012
- BG-00012
FAG 201- FAG 201
- 201, FAG
- FAG201
- FAG-201
BG 12 compound- BG 12 compound
- 12 compound, BG
- compound, BG 12
- BG12 compound
- compound, BG12
- BG-12 compound
|
Below are MeSH descriptors whose meaning is more general than "Dimethyl Fumarate".
Below are MeSH descriptors whose meaning is more specific than "Dimethyl Fumarate".
This graph shows the total number of publications written about "Dimethyl Fumarate" by people in this website by year, and whether "Dimethyl Fumarate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 4 | 1 | 5 |
| 2018 | 3 | 0 | 3 |
| 2019 | 1 | 1 | 2 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Dimethyl Fumarate" by people in Profiles.
-
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies. CNS Drugs. 2021 03; 35(3):317-330.
-
COVID-19 in multiple sclerosis patients treated with dimethyl fumarate. J Neurol. 2021 Sep; 268(9):3132-3134.
-
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. Ann Neurol. 2021 04; 89(4):780-789.
-
Dimethyl Fumarate Can Enhance the Potential Therapeutic Effects of Epidermal Neural Crest Stem Cells in COVID-19 Patients. Stem Cell Rev Rep. 2021 02; 17(1):300-301.
-
SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat Commun. 2020 10 02; 11(1):4938.
-
Impact of coronavirus disease (COVID-19) pandemic on multiple sclerosis care. Clin Neurol Neurosurg. 2020 10; 197:106203.
-
Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients. Biochemistry (Mosc). 2020 Jul; 85(7):833-837.
-
COVID-19 in dimethyl fumarate-treated patients with multiple sclerosis. J Neurol. 2021 Jun; 268(6):2023-2025.
-
COVID-19 will change MS care forever - No. Mult Scler. 2020 09; 26(10):1149-1151.
-
COVID-19 in MS: Initial observations from the Pacific Northwest. Neurol Neuroimmunol Neuroinflamm. 2020 09 03; 7(5).